Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.

Date
2006-AugAuthor
H Pakdaman
A Fallah
M A Sahraian
R Pakdaman
A Meysamie
Metadata
Show full item recordAbstract
Patients with early onset multiple sclerosis may develop disability at a younger age than adults. There are several reports about safety of beta interferons in childhood and juvenile MS with different doses.